Business Context and Reporting Period
This Form 8-K was filed by CHF Solutions, Inc. (noting the metadata reference to Nuwellis, Inc., the company's subsequent name) on November 27, 2017. The report details the closing of an underwritten public offering of equity securities.
Key Financial Metrics
- Gross Proceeds: $18 million received from the offering, prior to deducting underwriting discounts, commissions, and offering expenses.
- Capital Raised Structure:
- 18,000 shares of Series F Convertible Preferred Stock (convertible into approximately 4 million shares of Common Stock).
- Series 1 Warrants to purchase approximately 4 million shares of Common Stock (expiring in one year).
- Series 2 Warrants to purchase approximately 4 million shares of Common Stock (expiring in seven years).
- Outstanding Equity (as of Nov 27, 2017): 1,798,994 shares of Common Stock and 12,739 shares of Series F Convertible Preferred Stock.
- Pending Conversions: Notices received to convert an additional 1,861 shares of Series F Preferred Stock into 415,020 shares of Common Stock.
Material Changes
The primary material change is the significant increase in capitalization and potential share count resulting from the closing of the $18 million offering. The filing does not provide comparative financial data (revenue, profit, or cash flow) for prior periods as this is a transaction-specific report rather than a periodic financial statement.
Outlook, Risks, and Unusual Items
Management Commentary: The company entered into a Warrant Agency Agreement with American Stock Transfer & Trust Company, LLC to administer the warrants issued in the offering. Further terms are detailed in the effective Form S-1 (File No. 333-221010).
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard dilution implications of issuing convertible preferred stock and warrants. The filing text does not provide a clear value for net proceeds after expenses.
Investor Verification Checklist
- Verify the exact net proceeds after deducting underwriting discounts and offering expenses.
- Confirm the final share count once the pending conversion of 1,861 Series F shares is processed.
- Review the full Form S-1 (File No. 333-221010) for detailed use of proceeds and specific warrant exercise prices.
- Monitor the dilution impact of the 8 million shares of Common Stock potentially issuable via conversion and warrant exercise.